Alembic Pharmaceuticals Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
24.69 | 45.74 | -46.03% | 23.87 | +3.42% |
| P/S |
|
2.49 | 5.12 | -51.46% |
|
|
| P/BV |
|
3.16 | 6.3 | -49.92% |
|
|
| P/FCF |
|
28.6 | 168.72 | -83.05% |
|
|
| Ev/Ebitda |
|
17.77 | 13.54 | 31.23% |
|
|
| Ev/S |
|
2.54 | 4.77 | -46.76% |
|
|
| Ev/FCF |
|
32.61 | 163.7 | -80.08% |
|
|
| E/P |
|
0.0453 | 0.0451 | 0.4161% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
11.13 | 20.29 | -45.16% | 16.37 | -32.03% |
| ROE |
|
12.78 | 17.11 | -25.32% |
|
|
| ROA |
|
9.55 | 10.34 | -7.56% |
|
|
| ROIC |
|
0 | 10.89 | -100% |
|
|
| ROS |
|
10.08 | 11.98 | -15.87% |
|
|
| ROCE |
|
0 | 4.26 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.06 | 1.22 | -12.85% | 0.953 | +11.41% |
| Nеt Debt/Ebitda |
|
0.4562 | 1.06 | -56.9% |
|
|
| Debt/Ratio |
|
0.112 | 0.1307 | -14.3% |
|
|
| Debt/Equity |
|
0.2407 | 0.7972 | -69.81% |
|
|
| Debt/Net Income |
|
1.17 | 3.19 | -63.27% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.18/10
|
0.8659 | 11.92 | -92.74% | 1.52 | -42.91% |
| Number of years of dividend growth |
|
0 | 1.26 | -100% | ||
| DSI |
|
0.8571 | 0.8481 | 1.06% |
|
|
| Average dividend growth |
|
15.58 | -63.67 | -124.47% |
|
|
| Average percentage for 5 years |
|
1.52 | 11.6 | -86.93% |
|
|
| Average percentage for payments |
|
27.66 | 30.57 | -9.53% |
|
|
| Difference from average difference in sector |
|
-11.06 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
5/10
|
32.71 | 80.84 | -59.54% | ||
| Growth impulse Ebitda in 5 years |
|
-41.82 | 45.31 | -192.3% | ||
| Growth impulse Net Income in 5 years |
|
-25.7 | 131.41 | -119.56% | ||
| Growth impulse FCF in 5 years |
|
-266.47 | 76.02 | -450.53% | ||
| Growth impulse EPS in 5 years |
|
-18.89 | 286.48 | -106.59% |
IP Score
4.67/10
